Is JNJ Worth Buying in 2026?

Johnson & Johnson

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether Johnson & Johnson (JNJ) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 59 — healthy momentum range; strong 1-year return of +51.5%. Concerns: 50-day MA is falling (-0.88% over 10 days). Currently 7.5% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

JNJ is in a confirmed uptrend, trading above both its 50-day ($231.45) and 200-day ($213.13) moving averages. An RSI of 59.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +51.5% compares to +24.4% for SPY (beat the market by 27.1%).

$10,000 invested 1 year ago → $15,148 today
vs. S&P 500 (SPY) — same period beat market by 27.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($213.13)
Above 50-day MA ($231.45)
RSI(14) neutral zone (30–70) — currently 59.3
Positive return (+51.5%)
Within 10% of period high (−7.5%)
Period Range $232.77
$149.04 $251.71
RSI (14) 59.3
0 · OversoldOverbought · 100

Key Metrics

Price$232.77
Period Return+51.5%
Period High$251.71
Period Low$149.04
Drawdown−7.5%
MA-50$231.45
MA-200$213.13
RSI (14)59.3
Avg Volume (30d)7.5M
vs. SPYbeat by 27.1%
Return Rank#350 of 1245

Trade JNJ

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers